Incannex Healthcare Inc. Line of Credit Facility, Interest Rate During Period
Incannex Healthcare Inc. (IXHL) reported Line of Credit Facility, Interest Rate During Period of 48.50% for the 9-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityInterestRateDuringPeriod · last filed 2025-05-15
- 2025-03-31: Line of Credit Facility, Interest Rate During Period 9 month 48.50%.
- 2024-12-31: Line of Credit Facility, Interest Rate During Period 6 month 48.50%.
| Period end | Line of Credit Facility, Interest Rate During Period 6 month | Line of Credit Facility, Interest Rate During Period 9 month |
|---|---|---|
| 2025-03-31 | 48.50% 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 48.50% 10-Q · filed 2025-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |